Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2

被引：3

作者：

Yang, Michael G. ^{[1
]}

Xiao, Zili ^{[1
]}

Zhao, Rulin ^{[1
]}

Tebben, Andrew J. ^{[1
]}

Wang, Bei ^{[1
]}

Cherney, Robert J. ^{[1
]}

Batt, Douglas G. ^{[1
]}

Brown, Gregory D. ^{[1
]}

Cvijic, Mary Ellen ^{[1
]}

Duncia, John, V ^{[1
]}

Gallela, Michael A. ^{[1
]}

Gardner, Daniel S. ^{[1
]}

Khandelwal, Purnima ^{[1
]}

Malley, Mary F. ^{[1
]}

Pang, Jian ^{[1
]}

Rose, Anne, V ^{[1
]}

Santella, Joseph B., III ^{[1
]}

Sarjeant, Amy A. ^{[1
]}

Xu, Songmei ^{[1
]}

Mathur, Arvind ^{[1
]}

Mandlekar, Sandhya ^{[1
]}

Vuppugalla, Ragini ^{[1
]}

Zhao, Qihong ^{[1
]}

Carter, Percy H. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2021年 / 12卷 / 06期

关键词：

CC chemokine receptor 2 (CCR2); CCR2; antagonist; Monocyte chemoattractant protein-1; Multiple sclerosis; TARGETS; BIOLOGY;

D O I：

10.1021/acsmedchemlett.1c00082

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

To improve the metabolic stability profile of BMS-741672 (1a), we undertook a structure-activity relationship study in our trisubstituted cyclohexylamine series. This ultimately led to the identification of 2d (BMS-753426) as a potent and orally bioavailable antagonist of CCR2. Compared to previous clinical candidate la, the tert-butyl amine 2d showed significant improvements in pharmacokinetic properties, with lower clearance and higher oral bioavailability. Furthermore, compound 2d exhibited improved affinity for CCRS and good activity in models of both monocyte migration and multiple sclerosis in the hCCR2 knock-in mouse. The synthesis of 2d was facilitated by the development of a simplified approach to key intermediate (4R)-9b that deployed a stereoselective reductive amination which may prove to be of general interest.

引用

下载

页码：969 / 975

页数：7

共 50 条

[21] Discovery of ubrogepant (MK-1602): A potent, selective and orally bioavailable CGRP receptor antagonist for the acute treatment of migraine
Fraley, Mark
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[22] Discovery of potent, orally bioavailable protease-activated receptor 4 antagonists
Marinier, Anne
Banville, Jacques
Bird, Eileen
Callejo, Mario
Deon, Daniel
Dube, Laurence
Gagnon, Marc
Giancarli, Mary
Guy, Julia
Harper, Tim
Lam, Patrick
Lavallee, Jean-Francois
Lawrence, Michael
Martel, Alain
Miller, Michael
O'Grady, Harold
Posy, Shoshana
Priestley, Scott
Remillard, Roger
Ruediger, Edward
Tremblay, Francois
Watson, Carol
Wong, Pancras
Yang, Jing
Bouvier, Michel
Seiffert, Dietmar
Wexler, Ruth
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[23] Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
Cherney, Robert J.
Brogan, John B.
Mo, Ruowei
Lo, Yvonne C.
Yang, Gengjie
Miller, Persymphonie B.
Scherle, Peggy A.
Molino, Bruce F.
Carter, Percy H.
Decicco, Carl P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 597 - 601
[24] Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
Xue, Chu-Biao
Wang, Anlai
Meloni, David
Zhang, Ke
Kong, Ling
Feng, Hao
Glenn, Joseph
Huang, Taisheng
Zhang, Yingxin
Cao, Ganfeng
Anand, Rajan
Zheng, Changsheng
Xia, Michael
Han, Qi
Robinson, D. J.
Storace, Lou
Shao, Lixin
Li, Mei
Brodmerkel, Carrie M.
Covington, Maryanne
Scherle, Peggy
Diamond, Sharon
Yeleswaram, Swamy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7473 - 7478
[25] Pharmacological characterization of MK-3207, a potent and orally bioavailable CGRP receptor antagonist
Salvatore, C. A.
Moore, E. L.
Hershey, J. C.
Lynch, J. J.
Regan, C. P.
Bell, I. M.
Gallicchio, S. N.
Graham, S. L.
Selnick, H. G.
Vacca, J. P.
Kane, S. A.
CEPHALALGIA, 2009, 29 : 139 - 139
[26] Discovery of novel, potent and orally bioavailable CRTH2 antagonists
Terasaka, Tadashi
Ito, Shinji
Zenkoh, Tatsuya
Hayashida, Hisashi
Matsuda, Hiroshi
Miyata, Junji
Nagata, Hiroshi
Takasuna, Yuji
Kobayashi, Miki
Takeuchi, Makoto
Ohta, Mitsuaki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[27] Discovery of AMG 333: A potent, orally bioavailable TRPM8 antagonist for the treatment of migraine
Horne, Daniel
Biswas, Kaustav
Brown, James
Gore, Vijay
Harried, Scott
Kaller, Matthew
Ma, Vu
Monenschein, Holger
Nguyen, Thomas
Zhong, Wenge
Bartberger, Michael
Davis, Carl
Rose, Mark
Horner, Michelle
Wu, Tian
Sandrock, Robert
Lehto, Sonya
Rao, Sara
Youngblood, Beth
Zhang, Maosheng
Zhu, Dawn
Gavva, Narender
Chen, Jian
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[28] In Vitro and In Vivo Metabolism and Pharmacokinetics of BMS-562086, a Potent and Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist
Zhou, Lian
Dockens, Randy C.
Liu-Kreyche, Peggy
Grossman, Scott J.
Iyer, Ramaswamy A.
DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1093 - 1103
[29] Discovery and early development of MK-1064: A potent, orally bioavailable, selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Roecker, Anthony J.
Mercer, Swati P.
Cox, Christopher D.
Fraley, Mark E.
Schreier, John D.
Steen, Justin T.
Tannenbaum, Pamela L.
Gotter, Anthony L.
Garson, Susan L.
Fox, Steven V.
Harrell, C. Meacham
Stevens, Joanne
Lemaire, Wei
Bruno, Joseph G.
Stellabott, Joyce
Higgins, John D.
Cabalu, Tamara D.
Cui, Dan
Prueksaritanont, Thomayant
Hartman, George D.
Young, Steven D.
Winrow, Christopher J.
Renger, John J.
Forman, Mark S.
Coleman, Paul J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[30] Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus
Fader, Lee
Brault, Martine
Desjardins, Jessica
Dansereau, Nathalie
Lamorte, Louie
Tremblay, Sonia
Bilodeau, Francois
Bordeleau, Josee
Duplessis, Martin
Gorys, Vida
Gillard, James
Gleason, James L.
James, Clint
Joly, Marc-Andre
Kuhn, Cyrille
Llinas-Brunet, Montse
Luo, Laibin
Morency, Louis
Morin, Sebastien
Parisien, Mathieu
Poirier, Maude
Thibeault, Carl
Thao Trinh
Sturino, Claudio
Srivastava, Sanjay
Yoakim, Christiane
Franti, Michael
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (05): : 525 - 530

← 1 2 3 4 5 →